|Articles|April 1, 2004

Pharmacy Times

  • Volume 0
  • 0

Scientists Identify a Novel Protein

The discovery of a new protein that is crucial for the absorption of cholesterol in the intestines could have promising results. Researchers believe that it could lead to new drugs that lower an individual's cholesterol levels by preventing cholesterol from entering the body in the first place. The protein?Niemann-Pick C1 Like 1 (NPC1L1)?was identified after the researchers used various laboratory techniques to search for genes involved with cholesterol absorption.

Additional testing showed that the NPC1L1 gene encodes a protein that plays a critical role in the intestinal absorption of cholesterol. Also, this protein was found throughout the small intestines. In an effort to grasp NPC1L1 effects, the scientists assessed mice missing this gene. These mice showed a 70% reduction in absorbed cholesterol, compared with normal mice. (The findings were published in Science, February 20, 2004.)

Articles in this issue

over 21 years ago

RxPRODUCT NEWS PROFILE: Caduet

over 21 years ago

COMPOUNDING HOTLINE

over 21 years ago

Case Studies

over 21 years ago

Buddies Are Good for the Heart

over 21 years ago

Rage Is Connected to Stroke Risk

over 21 years ago

InnoLet

over 21 years ago

Colace/Peri-Colace

over 21 years ago

TampAlerT

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.


Latest CME